Clinical Trial

Comparison of Amniotic Membrane Dressing and Aquacel®Ag in Second-degree Burns

Enrolling by Invitation
View on ClinicalTrials.gov →
Record status
This record was last updated February 6, 2026 (before its estimated July 1, 2026 completion). Its status may not reflect the trial's current state.
Summary
To compare the outcome of amniotic membrane dressing versus Aquacel® Ag dressing with respect to the duration of healing in patients with second-degree burns within the local demographic setting. This study aims to address the existing gap in the literature by comparing the efficacy of amniotic membrane dressing and Aquacel® Ag dressing in the management of second-degree burns. Although Aquacel® Ag has been extensively studied for partial-thickness burns, it has not been directly compared with human amniotic membrane dressing, and no randomized controlled trial has yet evaluated these two treatment modalities. The findings of this study are expected to provide healthcare providers with an effective and cost-efficient dressing option for burn patients, particularly in resource-limited countries, while minimizing morbidity.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-12-10; most recent amendment 2026-02-05.
Trial Details
NCT Number NCT07300137
Lead Sponsor Patel Hospital, Pakistan
Conditions Second Degree Burns
Enrollment 100 participants
Start Date 2025-09-20
Primary Completion 2026-07-01 (estimated)
Study Completion 2026-08-01 (estimated)
Updated on ClinicalTrials.gov 2026-02-06